Ilse R. Wiechers, MD

Yale School of Medicine, New Haven,; VA Office of Mental Health and Suicide Prevention, Washington, DC; University of California San Francisco School of Medicine, San Francisco, California

JCP
Clinical Outcomes of IV Ketamine for Depression
Original Research

January 8, 2024

Short-term clinical trials found intravenous (IV) ketamine to be effective in reducing depressive symptoms. This study assessed longer-term outcomes of IV ketamine for depression and explored treatment and patient...
, , , et al
JCP
Article

April 26, 2017

Prescriptions of antidepressants, benzodiazepines, and sedative-hypnotics have increased in older adults, even among patients with no mental health diagnosis. Read this journal CME article comparing trends in psychiatry versus...
, , , et al
JCP
Perspective

November 15, 2009

, ,

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe